GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little ...

Binge eating disorder is strongly associated with weight gain and obesity, though not all individuals with obesity have BED.

New research reveals weight-loss drugs help during treatment but weight returns rapidly after stopping. Experts urge ...

This new drug is a jab at Ozempic. Tirzepatide, a weekly injectable that rivals celebrity-favorite Wegovy, is one step closer to approval for weight loss by the Food and Drug Administration after ...

People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...

,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia.. The drug, tirzepatide, is sold under the brand name Mounjaro and affects feelings of hunger and ...

Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound treat diabetes, support weight loss The weight loss drugs differ in FDA-approved uses ...

A groundbreaking study has revealed that GLP-1 receptor agonists—including popular weight-loss and diabetes drugs like ...

The researchers analyzed the weight loss of more than 18,000 adults who took Mounjaro or Ozempic between May 2022 and September 2023. By three months, Mounjaro patients shed 5.9% of their body ...

Patients put on weight loss drugs like Ozempic and Wegovy may start regaining weight within weeks of discontinuing them, a ...